These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 4606613)

  • 1. Heterogeneity of antinucleolar antibody and IgE antinuclear antibody in patients with systemic rheumatic diseases.
    Miyawaki S; Ritchie RF
    J Immunol; 1974 Oct; 113(4):1346-52. PubMed ID: 4606613
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antinuclear antibodies in disseminated lupus erythematosus and other connective tissue diseases].
    Velasco M; Losada M; Losada A; Ramirez G
    Rev Med Chil; 1968 Aug; 96(8):517-21. PubMed ID: 4915546
    [No Abstract]   [Full Text] [Related]  

  • 3. Antinuclear antibodies in some internal diseases, especially autoimmunization diseases.
    Lange A
    Arch Immunol Ther Exp (Warsz); 1972; 20(2):209-26. PubMed ID: 4112512
    [No Abstract]   [Full Text] [Related]  

  • 4. [Determination of the immunoglobulin type of complement fixing and non-fixing anti-nuclear factors].
    Peltier AP; Strejcek G
    Rev Fr Etud Clin Biol; 1969 Oct; 14(8):787-95. PubMed ID: 4189485
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dermatopathy and immunoglobulin].
    Niwa Y
    Hifuka Kiyo; 1970 Nov; 65(3):185-211. PubMed ID: 4105518
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antinuclear factors in rheumatoid arthritis (RA): differentiation of the binding pattern, the H and L chains and demonstration of complement fixation by means of indirect immunofluorescence].
    Dreher R
    Verh Dtsch Ges Rheumatol; 1978; 5():103-6. PubMed ID: 100982
    [No Abstract]   [Full Text] [Related]  

  • 7. Complement fixing activity and immunoglobulin classes of antinuclear antibodies occurring in systemic lupus erythematosus and rheumatoid arthritis.
    Massonnet-Castel S; Cassuto JP; Rioche M; Mucchielli A; Masseyeff R
    Biomedicine; 1981 Feb; 34(1):40-6. PubMed ID: 6971657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological diagnosis of rheumatoid arthritis and systemic lupus erythematosus.
    Wager O
    Ann Clin Res; 1975 Jun; 7(3):168-82. PubMed ID: 1103712
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative studies of the demonstration of antinuclear factors by immunofluorescence and antiglobulin consumption tests].
    Schmidt K; Mueller-Eckhardt C; Becker W
    Verh Dtsch Ges Rheumatol; 1969; 1():251-8. PubMed ID: 4934585
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lupus erythematosus-like syndrome with antimitochondrial antibodies].
    Maas D; Schubothe H
    Dtsch Med Wochenschr; 1973 Jan; 98(4):131-9. PubMed ID: 4567373
    [No Abstract]   [Full Text] [Related]  

  • 11. Complement-fixing granulocyte-specific antinuclear factors in neutropenic cases of rheumatoid arthritis.
    Wiik A; Munthe E
    Immunology; 1974 Jun; 26(6):1127-34. PubMed ID: 4604253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class specific antinuclear antibodies in systemic lupus erythematosus.
    Savitri K; Sehgal S; Datta BN; Chugh KS
    Indian J Med Res; 1993 Feb; 98():27-9. PubMed ID: 8495986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restrictions among heavy and light chain determinants of granulocyte-specific antinuclear factors.
    Wiik A; Munthe E
    Immunology; 1972 Jul; 23(1):53-60. PubMed ID: 4114648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunoelectrophoretic changes in rheumatic diseases].
    Arsov D; Guceva B; Hrisoho R; Caparoski L
    Acta Med Iugosl; 1971; 25(3):307-14. PubMed ID: 5134157
    [No Abstract]   [Full Text] [Related]  

  • 15. [Optic immunofluorescence demonstration of monoclonal and polyclonal antinuclear antibodies (ANA) in rheumatoid arthritis (RA) and lupus erythematosus disseminatus (LED)].
    Dreher R; Helmke K
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():808-13. PubMed ID: 417508
    [No Abstract]   [Full Text] [Related]  

  • 16. Antinuclear autoantibodies of IgD class. An analysis of 82 patients.
    Schmidt K; Mueller-Eckhardt C
    Z Immunitatsforsch Exp Klin Immunol; 1973 Sep; 145(5):385-91. PubMed ID: 4282956
    [No Abstract]   [Full Text] [Related]  

  • 17. [The immunoglobulins in ankylosing spondylitis].
    Kriegel W; Burger R; Kapp W; Alexopulos J
    Verh Dtsch Ges Rheumatol; 1969; 1():206-11. PubMed ID: 5314829
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitative studies of immunofluorescent staining. VI. Defined complement immunofluorescent staining for antinuclear antibodies in systemic lupus and other collagen diseases.
    Diaz Gill GA; Beutner EH; Eisenberg RB
    Int Arch Allergy Appl Immunol; 1973; 45(6):868-79. PubMed ID: 4586867
    [No Abstract]   [Full Text] [Related]  

  • 19. Lupus erythematosus: an autoimmune disease of the nervous system?
    Burton RC; McDuffie FC; Mulder DW
    Res Publ Assoc Res Nerv Ment Dis; 1971; 49():197-214. PubMed ID: 4109092
    [No Abstract]   [Full Text] [Related]  

  • 20. Systemic lupus erythematosus and the crithidia luciliae immunofluorescent test. A comparative study with an adapted Farr radioimmunoassay.
    Whitehouse IJ; Fehr K; Wagenhäuser FJ
    Z Rheumatol; 1983; 42(1):28-35. PubMed ID: 6342296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.